Key result
Aspirin intake of 100 mg/day for 14 days significantly decreased the maximal platelet aggregation rate induced by 1.6 mg/L collagen from 85.5% to 51.5%.
Why the study?
Does aspirin 100 mg/day alter whole-blood aggregation as measured by the screen filtration pressure method in healthy male volunteers?
Population
35 healthy male volunteers, aged 26-48 years, based in Japan. Key inclusion: no drugs affecting platelet…
Design
Cohort
Follow-up
14 days (21 days for a subset of 9 subjects)
Authors
Loading...
Supports screen filtration pressure method as surrogate for aspirin monitoring in healthy volunteers; leaves open translation to patients or outcomes.
Does aspirin 100 mg/day alter whole-blood aggregation as measured by the screen filtration pressure method in healthy male volunteers?
Absolute Event Rate: 51.5% vs 85.5%
p-value: p=<0.0001
Whole-blood aggregation measured by the screen filtration pressure method is a feasible and accurate surrogate marker for monitoring the antiplatelet efficacy of aspirin therapy.
Tabuchi et al. (2008) studied Healthy volunteers (n=35). Aspirin vs. Baseline (pre-intervention) was evaluated on Maximal aggregation rate induced by 1.6 mg/L collagen (p=<0.0001). Aspirin intake of 100 mg/day for 14 days significantly decreased the maximal platelet aggregation rate induced by 1.6 mg/L collagen from 85.5% to 51.5%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: